APO Research
Talk to an analyst

APO RESEARCH · REPORT

Disulfiramab Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Disulfiramab Injection Industry Growth and Trends Forecast to 2032

29 December 202572 pages

Choose your research edition.

Industry ResearchDisulfiramab Injection Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Disulfiramab Injection Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Disulfiramab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Disulfiramab Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Disulfiramab Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Disulfiramab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Disulfiramab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Disulfiramab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Disulfiramab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Disulfiramab Injection include Amgen Inc., BeiGene, Boan Biotech and Luye Pharma Gr, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Disulfiramab Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Disulfiramab Injection market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Disulfiramab Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Disulfiramab Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Disulfiramab Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Disulfiramab Injection Market by Company

Amgen Inc.

BeiGene

Boan Biotech

Luye Pharma Gr

Disulfiramab Injection Segment by Type

Adults

Minors

Disulfiramab Injection Segment by Application

Clinical

Research Institute

Disulfiramab Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Disulfiramab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Disulfiramab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Disulfiramab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Disulfiramab Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Disulfiramab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adults Table 2. Major Company of Minors Table 3. Global Disulfiramab Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 5. Global Disulfiramab Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Disulfiramab Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Disulfiramab Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Disulfiramab Injection Price by Type (2021-2026) & (US$/Kg) Table 9. Global Disulfiramab Injection Sales by Type (2027-2032) & (Kg) Table 10. Global Disulfiramab Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Disulfiramab Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Disulfiramab Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Disulfiramab Injection Price by Type (2027-2032) & (US$/Kg) Table 14. North America Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 15. North America Disulfiramab Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 17. Europe Disulfiramab Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Disulfiramab Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 21. Latin America Disulfiramab Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Disulfiramab Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Disulfiramab Injection Industry Trends Table 25. Disulfiramab Injection Industry Drivers Table 26. Disulfiramab Injection Industry Opportunities and Challenges Table 27. Disulfiramab Injection Industry Restraints Table 28. Global Disulfiramab Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Disulfiramab Injection Revenue Market Share by Company (2021-2026) Table 30. Global Disulfiramab Injection Sales by Company (2021-2026) & (Kg) Table 31. Global Disulfiramab Injection Sales Share by Company (2021-2026) Table 32. Global Disulfiramab Injection Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Disulfiramab Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Disulfiramab Injection Major Company Production Sites and Headquarters Table 35. Global Disulfiramab Injection Company, Product Type & Application Table 36. Global Disulfiramab Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Disulfiramab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Disulfiramab Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Disulfiramab Injection Sales by Region (2021-2026) & (Kg) Table 41. Global Disulfiramab Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Disulfiramab Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Disulfiramab Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Disulfiramab Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Disulfiramab Injection Sales by Region (2027-2032) & (Kg) Table 46. Global Disulfiramab Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Disulfiramab Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Disulfiramab Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Disulfiramab Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Disulfiramab Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 52. Global Disulfiramab Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Disulfiramab Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Disulfiramab Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Disulfiramab Injection Price by Application (2021-2026) & (US$/Kg) Table 56. Global Disulfiramab Injection Sales by Application (2027-2032) & (Kg) Table 57. Global Disulfiramab Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Disulfiramab Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Disulfiramab Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Disulfiramab Injection Price by Application (2027-2032) & (US$/Kg) Table 61. North America Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 62. North America Disulfiramab Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 64. Europe Disulfiramab Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Disulfiramab Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 68. Latin America Disulfiramab Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Disulfiramab Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Amgen Inc. Company Information Table 72. Amgen Inc. Business Overview Table 73. Amgen Inc. Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Amgen Inc. Disulfiramab Injection Product Portfolio Table 75. Amgen Inc. Recent Development Table 76. BeiGene Company Information Table 77. BeiGene Business Overview Table 78. BeiGene Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. BeiGene Disulfiramab Injection Product Portfolio Table 80. BeiGene Recent Development Table 81. Boan Biotech Company Information Table 82. Boan Biotech Business Overview Table 83. Boan Biotech Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Boan Biotech Disulfiramab Injection Product Portfolio Table 85. Boan Biotech Recent Development Table 86. Luye Pharma Gr Company Information Table 87. Luye Pharma Gr Business Overview Table 88. Luye Pharma Gr Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Luye Pharma Gr Disulfiramab Injection Product Portfolio Table 90. Luye Pharma Gr Recent Development Table 91. North America Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 92. North America Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 93. North America Disulfiramab Injection Sales Market Share by Country (2021-2026) Table 94. North America Disulfiramab Injection Sales Forecast by Country (2027-2032) & (Kg) Table 95. North America Disulfiramab Injection Sales Market Share Forecast by Country (2027-2032) Table 96. North America Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Disulfiramab Injection Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Disulfiramab Injection Market Share by Country (2021-2026) Table 99. North America Disulfiramab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Disulfiramab Injection Market Share Forecast by Country (2027-2032) Table 101. Europe Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 102. Europe Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 103. Europe Disulfiramab Injection Sales Market Share by Country (2021-2026) Table 104. Europe Disulfiramab Injection Sales Forecast by Country (2027-2032) & (Kg) Table 105. Europe Disulfiramab Injection Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Disulfiramab Injection Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Disulfiramab Injection Market Share by Country (2021-2026) Table 109. Europe Disulfiramab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Disulfiramab Injection Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 113. Asia-Pacific Disulfiramab Injection Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Disulfiramab Injection Sales Forecast by Country (2027-2032) & (Kg) Table 115. Asia-Pacific Disulfiramab Injection Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Disulfiramab Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Disulfiramab Injection Market Share by Country (2021-2026) Table 119. Asia-Pacific Disulfiramab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Disulfiramab Injection Market Share Forecast by Country (2027-2032) Table 121. Latin America Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. Latin America Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 123. Latin America Disulfiramab Injection Sales Market Share by Country (2021-2026) Table 124. Latin America Disulfiramab Injection Sales Forecast by Country (2027-2032) & (Kg) Table 125. Latin America Disulfiramab Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Disulfiramab Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Disulfiramab Injection Market Share by Country (2021-2026) Table 129. Latin America Disulfiramab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Disulfiramab Injection Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 133. Middle East and Africa Disulfiramab Injection Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Disulfiramab Injection Sales Forecast by Country (2027-2032) & (Kg) Table 135. Middle East and Africa Disulfiramab Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Disulfiramab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Disulfiramab Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Disulfiramab Injection Market Share by Country (2021-2026) Table 139. Middle East and Africa Disulfiramab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Disulfiramab Injection Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Disulfiramab Injection Distributors List Table 144. Disulfiramab Injection Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Disulfiramab Injection Image Figure 2. Global Disulfiramab Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Disulfiramab Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Disulfiramab Injection Sales (2021-2032) & (Kg) Figure 5. Adults Image Figure 6. Global Adults Sales YoY Growth (2021-2032) & (Kg) Figure 7. Minors Image Figure 8. Global Minors Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Disulfiramab Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Disulfiramab Injection Market Share by Type 2025 VS 2032 Figure 11. North America Disulfiramab Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Disulfiramab Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Disulfiramab Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Disulfiramab Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Disulfiramab Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Disulfiramab Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Disulfiramab Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Disulfiramab Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Disulfiramab Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Disulfiramab Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Disulfiramab Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinical Image Figure 24. Global Clinical Sales YoY Growth (2021-2032) & (Kg) Figure 25. Research Institute Image Figure 26. Global Research Institute Sales YoY Growth (2021-2032) & (Kg) Figure 27. Global Disulfiramab Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Disulfiramab Injection Market Share by Application 2025 VS 2032 Figure 29. North America Disulfiramab Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Disulfiramab Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Disulfiramab Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Disulfiramab Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Disulfiramab Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Disulfiramab Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Disulfiramab Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Disulfiramab Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Disulfiramab Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Disulfiramab Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Disulfiramab Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 40. North America Disulfiramab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Disulfiramab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Disulfiramab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Disulfiramab Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. Europe Disulfiramab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Disulfiramab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Disulfiramab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Disulfiramab Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Asia-Pacific Disulfiramab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Disulfiramab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Disulfiramab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Disulfiramab Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Latin America Disulfiramab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Disulfiramab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Disulfiramab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Disulfiramab Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Middle East and Africa Disulfiramab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Disulfiramab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Disulfiramab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Disulfiramab Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Disulfiramab Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Adults
  • Minors
Applications
  • Clinical
  • Research Institute
Companies covered
  • Amgen Inc.
  • BeiGene
  • Boan Biotech
  • Luye Pharma Gr

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Disulfiramab Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Disulfiramab Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Disulfiramab Injection Market by Type
  6. 1.3.1 Adults
  7. 1.3.2 Minors
  8. 1.4 Global Disulfiramab Injection Market Size by Type
  9. 1.4.1 Global Disulfiramab Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Disulfiramab Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Disulfiramab Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Disulfiramab Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Disulfiramab Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Disulfiramab Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Disulfiramab Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Disulfiramab Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Disulfiramab Injection Industry Trends
  2. 2.2 Disulfiramab Injection Industry Drivers
  3. 2.3 Disulfiramab Injection Industry Opportunities and Challenges
  4. 2.4 Disulfiramab Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Disulfiramab Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Disulfiramab Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Disulfiramab Injection Price (2021-2026)
  4. 3.4 Global Disulfiramab Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Disulfiramab Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Disulfiramab Injection Company, Product Type & Application
  7. 3.7 Global Disulfiramab Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Disulfiramab Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Disulfiramab Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Disulfiramab Injection Tier 1, Tier 2, and Tier 3
4 Disulfiramab Injection Regional Status and Outlook
  1. 4.1 Global Disulfiramab Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Disulfiramab Injection Historic Market Size by Region
  3. 4.2.1 Global Disulfiramab Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Disulfiramab Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Disulfiramab Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Disulfiramab Injection Forecasted Market Size by Region
  7. 4.3.1 Global Disulfiramab Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Disulfiramab Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Disulfiramab Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Disulfiramab Injection by Application
  1. 5.1 Disulfiramab Injection Market by Application
  2. 5.1.1 Clinical
  3. 5.1.2 Research Institute
  4. 5.2 Global Disulfiramab Injection Market Size by Application
  5. 5.2.1 Global Disulfiramab Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Disulfiramab Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Disulfiramab Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Disulfiramab Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Disulfiramab Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Disulfiramab Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Disulfiramab Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Disulfiramab Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen Inc.
  2. 6.1.1 Amgen Inc. Company Information
  3. 6.1.2 Amgen Inc. Business Overview
  4. 6.1.3 Amgen Inc. Disulfiramab Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen Inc. Disulfiramab Injection Product Portfolio
  6. 6.1.5 Amgen Inc. Recent Developments
  7. 6.2 BeiGene
  8. 6.2.1 BeiGene Company Information
  9. 6.2.2 BeiGene Business Overview
  10. 6.2.3 BeiGene Disulfiramab Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BeiGene Disulfiramab Injection Product Portfolio
  12. 6.2.5 BeiGene Recent Developments
  13. 6.3 Boan Biotech
  14. 6.3.1 Boan Biotech Company Information
  15. 6.3.2 Boan Biotech Business Overview
  16. 6.3.3 Boan Biotech Disulfiramab Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boan Biotech Disulfiramab Injection Product Portfolio
  18. 6.3.5 Boan Biotech Recent Developments
  19. 6.4 Luye Pharma Gr
  20. 6.4.1 Luye Pharma Gr Company Information
  21. 6.4.2 Luye Pharma Gr Business Overview
  22. 6.4.3 Luye Pharma Gr Disulfiramab Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Luye Pharma Gr Disulfiramab Injection Product Portfolio
  24. 6.4.5 Luye Pharma Gr Recent Developments
7 North America by Country
  1. 7.1 North America Disulfiramab Injection Sales by Country
  2. 7.1.1 North America Disulfiramab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Disulfiramab Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Disulfiramab Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Disulfiramab Injection Market Size by Country
  6. 7.2.1 North America Disulfiramab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Disulfiramab Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Disulfiramab Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Disulfiramab Injection Sales by Country
  2. 8.1.1 Europe Disulfiramab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Disulfiramab Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Disulfiramab Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Disulfiramab Injection Market Size by Country
  6. 8.2.1 Europe Disulfiramab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Disulfiramab Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Disulfiramab Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Disulfiramab Injection Sales by Country
  2. 9.1.1 Asia-Pacific Disulfiramab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Disulfiramab Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Disulfiramab Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Disulfiramab Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Disulfiramab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Disulfiramab Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Disulfiramab Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Disulfiramab Injection Sales by Country
  2. 10.1.1 South America Disulfiramab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Disulfiramab Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Disulfiramab Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Disulfiramab Injection Market Size by Country
  6. 10.2.1 South America Disulfiramab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Disulfiramab Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Disulfiramab Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Disulfiramab Injection Sales by Country
  2. 11.1.1 Middle East and Africa Disulfiramab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Disulfiramab Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Disulfiramab Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Disulfiramab Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Disulfiramab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Disulfiramab Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Disulfiramab Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Disulfiramab Injection Value Chain Analysis
  2. 12.1.1 Disulfiramab Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Disulfiramab Injection Production Mode & Process
  7. 12.2 Disulfiramab Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Disulfiramab Injection Distributors
  10. 12.2.3 Disulfiramab Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst